TNBC represents 15% of breast carcinomas and is defined by the absence of the three main breast cancer biomarkers: lack of expression of estrogen receptors and progesterone receptors and lack of amplification or overexpression of HER-2 (also known as ERB2). Here, ESR1 is linked to breast carcinoma.